The DOI matches its Crossref record; 31 of the 31 references it cites were found in a registry or an index.
QT-Interval Effects of Methadone, Levomethadyl, and Buprenorphine in a Randomized Trial
Abstract
BACKGROUND: Levomethadyl acetate, methadone hydrochloride, and buprenorphine hydrochloride are equally effective treatments for opioid dependence. Each blocks the human ether-a-go-go-related gene (hERG)-associated channel in vitro and represents a risk for QT prolongation. To compare the effects of 3 known hERG-associated channel blockers on the corrected QT (QTc), we conducted a randomized, controlled trial of opioid-addicted subjects. METHODS: We analyzed 12-lead electrocardiograms collected at baseline and every 4 weeks from 165 opioid-addicted participants in a 17-week randomized double-blind clinical trial of equally effective doses of levomethadyl, methadone, and buprenorphine at a major referral center. Analyses were limited to the 154 patients with a normal baseline QTc = (QT/ radical R-R) who had at least 1 subsequent in-treatment electrocardiogram. Patients were randomized to receive treatment with levomethadyl, methadone, or buprenorphine (hereinafter, levomethadyl, methadone, and buprenorphine groups, respectively). The prespecified end points were a QTc greater than 470 milliseconds in men (or >490 milliseconds in women), or an increase from baseline in QTc greater than 60 milliseconds. RESULTS: Baseline QTc was similar in the 3 groups. The levomethadyl and methadone groups were significantly more likely to manifest a QTc greater than 470 or 490 milliseconds (28% for the levomethadyl group vs 23% for the methadone group vs 0% for the buprenorphine group; P < .001) or an increase from baseline in QTc greater than 60 milliseconds (21% of the levomethadyl group [odds ratio, 15.8; 95% confidence interval, 3.7-67.1] and 12% of the methadone group [odds ratio, 8.4; 95% confidence interval, 1.9-36.4]) compared with the buprenorphine group (2% of subjects; P < .001). In subjects whose dosage of levomethadyl or methadone remained fixed over at least 8 weeks, the QTc continued to increase progressively over time (P = .08 for the levomethadyl group, P = .01 for the methadone group). CONCLUSION: Buprenorphine is associated with less QTc prolongation than levomethadyl or methadone and may be a safe alternative.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Models for Longitudinal Data: A Generalized Estimating Equation Approach
Zeger, S. L., Liang, K.-Y., & Albert, P. S. (1988) · Biometrics · doi:10.2307/2531734 · Cited by 4,505
Sanguinetti, M. C., Jiang, C., Curran, M. E., & Keating, M. T. (1995) · Cell · doi:10.1016/0092-8674(95)90340-2 · Cited by 2,423
Drug-induced prolongation of the QT interval
Roden, D. M. (2004) · New England Journal of Medicine · doi:10.1056/nejmra032426 · Cited by 1,965
Using SAS PROC MIXED to Fit Multilevel Models, Hierarchical Models, and Individual Growth Models
Singer, J. D. (1998) · Journal of Educational and Behavioral Statistics · doi:10.2307/1165280 · Cited by 1,092
Die Systolendauer im Elektrokardiogramm bei normalen Menschen und bei Herzkranken
FRIDERICIA, L. S. (1920) · Acta Medica Scandinavica · doi:10.1111/j.0954-6820.1920.tb18266.x · Cited by 1,000
An improved method for adjusting the QT interval for heart rate (the Framingham Heart Study)
Sagie, A., Larson, M. G., Goldberg, R. J., Bengtson, J. R., & Levy, D. (1992) · The American Journal of Cardiology · doi:10.1016/0002-9149(92)90562-d · Cited by 715
A Comparison of Levomethadyl Acetate, Buprenorphine, and Methadone for Opioid Dependence
Johnson, R. E., Chutuape, M. A., Strain, E. C., Walsh, S. L., Stitzer, M. L., & Bigelow, G. E. (2000) · New England Journal of Medicine · doi:10.1056/nejm200011023431802 · Cited by 623
Application of a Method of Estimating DIF for Polytomous Test Items
Camilli, G., & Congdon, P. (1999) · Journal of Educational and Behavioral Statistics · doi:10.2307/1165366 · Cited by 607
A Controlled Trial of Buprenorphine Treatment for Opioid Dependence
Johnson, R. E. (1992) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1992.03480200058024 · Cited by 572
Measurement of the QT interval and the risk associated with QTc interval prolongation: A review
Moss, A. J. (1993) · The American Journal of Cardiology · doi:10.1016/0002-9149(93)90036-c · Cited by 472
Torsade de Pointes Associated with Very-High-Dose Methadone
Krantz, M. J., Lewkowiez, L., Hays, H., Woodroffe, M. A., Robertson, A. D., & Mehler, P. S. (2002) · Annals of Internal Medicine · doi:10.7326/0003-4819-137-6-200209170-00010 · Cited by 426
Influence of Opioid Agonists on Cardiac Human Ether-a-go-go-related Gene K+ Currents
Katchman, A. N., McGroary, K. A., Kilborn, M. J., Kornick, C. A., Manfredi, P. L., Woosley, R. L., & Ebert, S. N. (2002) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.102.038240 · Cited by 264
Ehret, G. B., Voide, C., Gex-Fabry, M., Chabert, J., Shah, D., Broers, B., Piguet, V., Musset, T., Gaspoz, J.-M., Perrier, A., et al. (2006) · Archives of Internal Medicine · doi:10.1001/archinte.166.12.1280 · Cited by 233
Dose‐Related Effects of Methadone on QT Prolongation in a Series of Patients with Torsade de Pointes
Krantz, M. J., Kutinsky, I. B., Robertson, A. D., & Mehler, P. S. (2003) · Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy · doi:10.1592/phco.23.6.802.32186 · Cited by 232
Dose-Response Effects of Methadone in the Treatment of Opioid Dependence
Strain, E. C., Stitzer, M. L., Liebson, I. A., & Bigelow, G. E. (1993) · Annals of Internal Medicine · doi:10.7326/0003-4819-119-1-199307010-00004 · Cited by 224
EBERT, S. N., LIU, X.-K., & WOOSLEY, R. L. (1998) · Journal of Women's Health · doi:10.1089/jwh.1998.7.547 · Cited by 224
Indik, J. H., Pearson, E. C., Fried, K., & Woosley, R. L. (2006) · Heart Rhythm · doi:10.1016/j.hrthm.2006.05.023 · Cited by 166
Pentamidine reduces hERG expression to prolong the QT interval
Cordes, J. S., Sun, Z., Lloyd, D. B., Bradley, J. A., Opsahl, A., Tengowski, M. W., Chen, X., & Zhou, J. (2005) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0706140 · Cited by 128
Hickman, M. (2003) · Journal of Heredity · doi:10.1093/jurban/jtg030 · Cited by 108
Torsades de PointesAssociated with High Dose Levomethadyl Acetate (ORLAAM®)
Deamer, R. L., Wilson, D. R., Clark, D., & Prichard, J. G. (2001) · Journal of Addictive Diseases · doi:10.1300/j069v20n04_02 · Cited by 105
High dose methadone and ventricular arrhythmias: a report of three cases
Walker, P. W., Klein, D., & Kasza, L. (2003) · Pain · doi:10.1016/s0304-3959(02)00461-x · Cited by 104
The Impact of Methadone Induction on Cardiac Conduction in Opiate Users
Martell, B. A., Arnsten, J. H., Ray, B., & Gourevitch, M. N. (2003) · Annals of Internal Medicine · doi:10.7326/0003-4819-139-2-200307150-00021 · Cited by 96
Mortality in a cohort of opiate and amphetamine users in Perth, Western Australia
Bartu, A. E., Freeman, N. C., Gawthorne, G. S., Codde, J., & Holman, C. D. J. (2003) · Addiction · doi:10.1111/j.1360-0443.2004.00602.x · Cited by 95
Shah, R. R. (2002) · Fundamental and Clinical Pharmacology · doi:10.1046/j.1472-8206.2002.00083.x · Cited by 76
Chapman, H., Ramström, C., Korhonen, L., Laine, M., Wann, K. T., Lindholm, D., Pasternack, M., & Törnquist, K. (2005) · Journal of Cell Science · doi:10.1242/jcs.02635 · Cited by 72
Eissenberg, T. (1997) · JAMA · doi:10.1001/jama.1997.03540480045037 · Cited by 59
Protein trafficking abnormalities: a new mechanism in drug‐induced long QT syndrome
Eckhardt, L. L., Rajamani, S., & January, C. T. (2005) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0706143 · Cited by 52
Torsades de Pointes Due to Methadone
Bels, D. D., Staroukine, M., & Devriendt, J. (2003) · Annals of Internal Medicine · doi:10.7326/0003-4819-139-2-200307150-00021-w2 · Cited by 31
[Torsades de pointe. Apropos of 60 cases].
Salle, P., Jl, R., BERNASCONI, P. P., Jc, Q., & Lombaërt, M. (1985) · PubMed · Cited by 26
Milon, D., Daubert, J., Saint-Marc, C., & GOUFFAULT, J. (1982) · Annales Françaises d Anesthésie et de Réanimation · doi:10.1016/s0750-7658(82)80094-4 · Cited by 23
Effect of LAAM dose on opiate use in opioid-dependent patients. A pilot study.
Oliveto, A. H., Farren, C. K., & Kosten, T. R. (1998) · PubMed · Cited by 15
Cited by
QTc Interval Screening in Methadone Treatment
Krantz, M. J., Martin, J., Stimmel, B., Mehta, D., & Haigney, M. C. P. (2009) · Annals of Internal Medicine · doi:10.7326/0003-4819-150-6-200903170-00103 · Cited by 337
Veilleux, J. C., Colvin, P. J., Anderson, J., York, C., & Heinz, A. J. (2010) · Clinical Psychology Review · doi:10.1016/j.cpr.2009.10.006 · Cited by 336
Medication Treatment of Opioid Use Disorder
Bell, J., & Strang, J. (2020) · Biological Psychiatry · doi:10.1016/j.biopsych.2019.06.020 · Cited by 328
Kraus, M. L., Alford, D. P., Kotz, M. M., Levounis, P., Mandell, T. W., Meyer, M., Salsitz, E. A., Wetterau, N., & Wyatt, S. A. (2011) · Journal of Addiction Medicine · doi:10.1097/adm.0b013e3182312983 · Cited by 266
Chou, R., Cruciani, R. A., Fiellin, D. A., Compton, P., Farrar, J. T., Haigney, M. C., Inturrisi, C., Knight, J. R., Otis-Green, S., Marcus, S. M., et al. (2014) · The Journal of Pain · doi:10.1016/j.jpain.2014.01.494 · Cited by 262
Metadata
- Authors
- Wedam, E. F.
- Venue
- Archives of Internal Medicine
- Publisher
- American Medical Association (AMA)
- Published
- 2007-12-10
- Volume
- 167
- Issue
- 22
- Pages
- 2469
- ISSN
- 0003-9926 (ISSN-L)
- OpenAlex
- W2096235928
- Cited by
- 259
- References
- 31
- FWCI
- 18.25
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.